Skip to main content
Fig. 7 | Diabetology & Metabolic Syndrome

Fig. 7

From: Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR/p-ULK1 signaling pathway-mediated autophagy

Fig. 7

Empagliflozin promotes cardiac autophagy in diabetic mice through the mTOR/p-ULK1 pathway. A Protein expressions of SESN2, mTOR, p-ULK1, ULK1, LC3B, and P62 were identified by Western blotting. β-actin was considered as a loading control. B–G Data were expressed as the mean ± SEM. *P < 0.05 versus CTRL; **P < 0.01 versus CTRL; #P < 0.05 versus DM; ##P < 0.01 versus DM

Back to article page